Paul Sauer - Mar 10, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
/s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Mar 10, 2022
Transactions value $
-$150,000
Form type
4
Date filed
3/14/2022, 05:03 PM
Previous filing
Mar 4, 2022
Next filing
Mar 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$150K -6K -16.16% $25.00 31.1K Mar 10, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.